Active Ingredient: MIDAZOLAM
(Hérité de MIDAZOLAM ACCORD 1 mg/ml) Only one case report (https://doi.org/10.9734/IJMPCR/2015/18840) showed a QTc interval prolongation following high dosage of Midazolam
https://doi.org/10.1046/j.1365-2346.1996.00022.x, https://doi.org/10.9734/IJMPCR/2015/18840, https://doi.org/10.1093/bja/aet412, https://www.has-sante.fr/upload/docs/application/pdf/2021-10/1._protocole_national_de_diagnostic_et_de_soins_syndrome_du_qt_long_cardiogen_isabelle_denjoy.pdf, https://doi.org/10.1517/14656566.3.5.479